Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.

Authors:
Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Gonzalez-Gonzalez V and 4 more

Journal:
Clin Rheumatol

Publication Year: 2023

DOI:
10.1007/s10067-022-06486-4

PMCID:
PMC9838353

PMID:
36627529

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Rheumatol

Abbreviation: Clin Rheumatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Rheumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet.
Lichtiger A; Fadaei G; Tagoe CE. (2024) - Transparency Score: 2/6
Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic …
Amer AS; Abdel Moneam SM; Hashaad NI and 2 more (2024) - Transparency Score: 3/6
Content analysis of patient support groups related to myositis on Facebook.
Afsar AP; Ghosh S; Titus RS and 5 more (2024) - Transparency Score: 3/6
Cumulative pulse methylprednisolone and its relation to disease activity, damage and mortality in s…
Sobhy N; Ezzat Y; Gamal SM and 5 more (2024) - Transparency Score: 3/6
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic gro…
O'Brien J; Park SH; Blachley T and 4 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations The manuscript does not contain clinical studies or patient data. DisclosuresNone. Disclosures None."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025